AR043920A1 - Derivados de oxazol, su produccion y uso como agentes farmaceuticos - Google Patents
Derivados de oxazol, su produccion y uso como agentes farmaceuticosInfo
- Publication number
- AR043920A1 AR043920A1 ARP040100998A ARP040100998A AR043920A1 AR 043920 A1 AR043920 A1 AR 043920A1 AR P040100998 A ARP040100998 A AR P040100998A AR P040100998 A ARP040100998 A AR P040100998A AR 043920 A1 AR043920 A1 AR 043920A1
- Authority
- AR
- Argentina
- Prior art keywords
- oxazol
- derivatives
- production
- alkyl
- hydrogen
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical class C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La preparación de los compuestos anteriormente mencionados, los medicamentos que los contienen y su fabricación, así como el uso de los compuestos anteriormente mencionados en el control o prevención de enfermedades tales como el cáncer. Reivindicación 1: Los compuestos de fórmula (1), en donde: R1 es -O-alquilo; -S-alquilo; -NH-alquilo; y R2 es hidrógeno; o halógeno; o R1 y R2 junto con los átomos de carbono a los que se están unidos forman un anillo heterocíclico de 5 ó 6 miembros; y R3 es hidrógeno; o si R1 y R2 junto con los átomos de carbono a los que están unidos forman un anillo heterocíclico de 5 ó 6 miembros; R3 es hidrógeno; o halógeno y sus sales farmacéuticamente aceptables.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03007124 | 2003-03-28 | ||
| US45974103P | 2003-04-02 | 2003-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043920A1 true AR043920A1 (es) | 2005-08-17 |
Family
ID=36748274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100998A AR043920A1 (es) | 2003-03-28 | 2004-03-25 | Derivados de oxazol, su produccion y uso como agentes farmaceuticos |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7205325B2 (es) |
| EP (1) | EP1613623A1 (es) |
| JP (1) | JP2006515019A (es) |
| KR (1) | KR100842692B1 (es) |
| CN (1) | CN100386325C (es) |
| AR (1) | AR043920A1 (es) |
| AU (1) | AU2004224173A1 (es) |
| BR (1) | BRPI0408826A (es) |
| CA (1) | CA2519053A1 (es) |
| CL (1) | CL2004000630A1 (es) |
| CO (1) | CO5611130A2 (es) |
| HR (1) | HRP20050831A2 (es) |
| MX (1) | MXPA05010135A (es) |
| NO (1) | NO20054360L (es) |
| RU (1) | RU2005133073A (es) |
| TW (1) | TW200505913A (es) |
| WO (1) | WO2004085434A1 (es) |
| ZA (1) | ZA200506953B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7005526B2 (en) | 2004-05-25 | 2006-02-28 | Hoffmann-La Roche Inc. | Thioether derivatives |
| US20060116407A1 (en) * | 2004-11-22 | 2006-06-01 | Birgit Bossenmaier | Amide derivatives |
| TW200738680A (en) | 2005-08-04 | 2007-10-16 | Hoffmann La Roche | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| JP2009504586A (ja) * | 2005-08-08 | 2009-02-05 | エフ．ホフマン−ラ ロシュ アーゲー | ピラゾール誘導体、それらの製造及び医薬品としての使用 |
| RU2418793C2 (ru) * | 2005-11-15 | 2011-05-20 | Оцука Фармасьютикал Ко., Лтд. | Соединение оксазола и фармацевтическая композиция |
| CA2995617A1 (en) * | 2017-11-03 | 2019-05-03 | Universite De Montreal | Heterocyclic mitochondrial activity inhibitors and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK531479A (da) | 1979-01-19 | 1980-07-20 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
| GR71915B (es) | 1979-11-27 | 1983-08-16 | Pfizer | |
| DE3808283A1 (de) | 1988-03-12 | 1989-09-21 | Boehringer Ingelheim Kg | Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung |
| US5359078A (en) | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
| US5281593A (en) | 1990-07-31 | 1994-01-25 | Lilly Industries Limited | Certain indole derivatives useful as leukotriene antagonists |
| GB9122590D0 (en) | 1991-10-24 | 1991-12-04 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5322847A (en) | 1992-11-05 | 1994-06-21 | Pfizer Inc. | Azabenzimidazoles in the treatment of asthma, arthritis and related diseases |
| WO1995027700A1 (en) | 1994-04-08 | 1995-10-19 | Sumitomo Chemical Company, Limited | Ether compound, use thereof, and intermediate for producing the compound |
| US5883106A (en) | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| JPH09136877A (ja) | 1995-06-16 | 1997-05-27 | Takeda Chem Ind Ltd | 複素環化合物、その製造法及び用途 |
| DE19610882A1 (de) | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP0912562A1 (en) | 1996-07-19 | 1999-05-06 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
| CN1239889A (zh) | 1996-10-07 | 1999-12-29 | 伊莱利利公司 | 用作神经保护剂的新的化合物 |
| PE20011178A1 (es) | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | Compuestos heterociclicos y su produccion |
| EP1439178A4 (en) | 2001-10-05 | 2005-11-16 | Takeda Pharmaceutical | Heterocyclic compounds, oxazole derivatives, process for their preparation and their use |
| WO2003059907A1 (en) | 2002-01-17 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof |
-
2004
- 2004-03-23 TW TW093107822A patent/TW200505913A/zh unknown
- 2004-03-24 CL CL200400630A patent/CL2004000630A1/es unknown
- 2004-03-25 AR ARP040100998A patent/AR043920A1/es unknown
- 2004-03-25 US US10/808,935 patent/US7205325B2/en not_active Expired - Fee Related
- 2004-03-26 MX MXPA05010135A patent/MXPA05010135A/es active IP Right Grant
- 2004-03-26 KR KR1020057018151A patent/KR100842692B1/ko not_active Expired - Fee Related
- 2004-03-26 BR BRPI0408826-3A patent/BRPI0408826A/pt not_active IP Right Cessation
- 2004-03-26 CA CA002519053A patent/CA2519053A1/en not_active Abandoned
- 2004-03-26 AU AU2004224173A patent/AU2004224173A1/en not_active Abandoned
- 2004-03-26 EP EP04723580A patent/EP1613623A1/en not_active Withdrawn
- 2004-03-26 RU RU2005133073/04A patent/RU2005133073A/ru not_active Application Discontinuation
- 2004-03-26 JP JP2005518683A patent/JP2006515019A/ja active Pending
- 2004-03-26 CN CNB2004800083282A patent/CN100386325C/zh not_active Expired - Fee Related
- 2004-03-26 HR HR20050831A patent/HRP20050831A2/xx not_active Application Discontinuation
- 2004-03-26 WO PCT/EP2004/003205 patent/WO2004085434A1/en not_active Ceased
-
2005
- 2005-08-30 ZA ZA200506953A patent/ZA200506953B/en unknown
- 2005-09-20 NO NO20054360A patent/NO20054360L/no not_active Application Discontinuation
- 2005-09-23 CO CO05096775A patent/CO5611130A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005133073A (ru) | 2006-06-10 |
| US7205325B2 (en) | 2007-04-17 |
| CL2004000630A1 (es) | 2005-02-04 |
| US20040209933A1 (en) | 2004-10-21 |
| KR100842692B1 (ko) | 2008-07-01 |
| HRP20050831A2 (en) | 2006-09-30 |
| KR20050118688A (ko) | 2005-12-19 |
| BRPI0408826A (pt) | 2006-04-04 |
| NO20054360L (no) | 2005-10-11 |
| CO5611130A2 (es) | 2006-02-28 |
| WO2004085434A1 (en) | 2004-10-07 |
| CN1764660A (zh) | 2006-04-26 |
| TW200505913A (en) | 2005-02-16 |
| ZA200506953B (en) | 2006-05-31 |
| CN100386325C (zh) | 2008-05-07 |
| MXPA05010135A (es) | 2005-11-16 |
| CA2519053A1 (en) | 2004-10-07 |
| JP2006515019A (ja) | 2006-05-18 |
| EP1613623A1 (en) | 2006-01-11 |
| AU2004224173A1 (en) | 2004-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038419A1 (es) | Derivados de piridina y quinolina | |
| AR035892A1 (es) | Derivados de oxazol, proceso para su preparacion, composiciones farmaceuticas que los comprenden, y el uso de dichos compuestos en la preparacion de medicamentos | |
| BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
| AR064692A1 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
| AR054365A1 (es) | Derivados de heteroaril benzamidas, composiciones farmaceuticas que los contienen, usos en enfermedades mediadas por glucoquinasasy metodo de preparacion de los mismos. | |
| UY30408A1 (es) | Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
| CO5640117A2 (es) | Derivados de 2,4-diamonopirimidina | |
| AR040626A1 (es) | Derivados de quinolina utiles como ligandos del receptor del neuropeptido y (npy) | |
| MY139571A (en) | Indolyl derivatives as liver-x-receptor modulators | |
| AR030306A1 (es) | Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento | |
| SE0402735D0 (sv) | Novel compounds | |
| BR0313078A (pt) | Composto ou um sal deste farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou de um sal deste farmaceuticamente aceitável | |
| NI201000011A (es) | Derivados de pirimidina 934. | |
| CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
| AR081725A1 (es) | Derivados de oxadiazol, proceso de preparacion de los mismos, composicion farmaceutica que los contienen y su uso en el tratamiento del cancer | |
| AR065129A1 (es) | Derivados de 6-oxo-6,7-dihidro-5h-dibenzo(b,d)azepin-7-ilo | |
| AR066063A1 (es) | Derivados de triazol que son antagonistas de smo | |
| AR039988A1 (es) | Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos | |
| UY30397A1 (es) | Derivados sustituidos de la (3as, 7as)-1,3a,4,5,6,7-hexahidro-3h-benzoimidazol-2-ona, proceso de preparacion, composiciones conteniéndolos yaplicaciones | |
| HUP0002311A2 (hu) | Ergolinszármazékok és szomatosztatin receptorként való alkalmazásuk | |
| AR038704A1 (es) | Derivados de tiazol como antagonistas del receptor nyp | |
| PE20091182A1 (es) | DERIVADOS DE IMIDAZO[1,2-a]PIRIDIN-2-CARBOXAMIDAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| AR041079A1 (es) | Derivados de 2-ariltiazol como agonistas de receptores activados proliferadores de peroxisomas alfa y gamma (ppar alfa y gamma) | |
| AR043920A1 (es) | Derivados de oxazol, su produccion y uso como agentes farmaceuticos | |
| AR041481A1 (es) | Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |